Komori
Share Issuance and Disposal4263SUSMED,Inc.Information and Communications, Services and Others

Notice Regarding the Finalization of the Terms of the Stock Options (Share Acquisition Rights)

The issuance details that had remained undecided, including the number of employees to be allotted options, the number of options, the number of underlying shares and the exercise price, have been finalized for the employee stock options resolved on 22 July 2026.

Worth reading
39Recurring
Scored from 3 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
133000
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Issuance of share acquisition rights as stock options

Who receives how much133,000Shares

133,000 common shares

43 employees of the Company (1,330 options)

The lower thin line represents the existing number of shares to which these shares will be added.

Terms of the stock acquisition rights
Exercise price
Exercise price of ¥77,900 per share acquisition right and ¥779 per share. Amendment provisions and floor: Not disclosed
Number of Stock Acquisition Rights
Total number of options issued: 1,330; number of unexercised options: Not disclosed
Categories and Number of Persons Covered
43 employees of the Company, 1,330 stock acquisition rights
Details of issuance or disposal
ItemDetails
Type of issuance or disposalIssuance of share acquisition rights as stock options
Number of shares to be issued or disposed of133,000 common shares
Intended allottee43 employees of the Company (1,330 options)
Exercise priceExercise price of ¥77,900 per share acquisition right and ¥779 per share. Amendment provisions and floor: Not disclosed
Number of Stock Acquisition RightsTotal number of options issued: 1,330; number of unexercised options: Not disclosed
Categories and Number of Persons Covered43 employees of the Company, 1,330 stock acquisition rights
Items this document does not state (22)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The previously undecided details of the share acquisition rights to be issued to employees as stock options have been finalized.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Finalization of the Terms of the Stock Options (Share Acquisition Rights) | SUSMED,Inc. (4263) timely disclosure | Komori